Tilray Brands’ (TLRY) 2Q earnings were just released. Its adjusted EPS came in at $0.00 and its revenue came in at $193.77M. Tilray Brands backs FY24 adjusted EBITDA guidance of $68M-$78M. Morgan Paxhia and Alan Brochstein discuss takeaways from Tilray Brands’ earnings and other pot stocks such as Cronos Group (CRON). They then go over the regulatory outlook for cannabis companies. Tune in to find out more about the stock market today.
#investing #trading #finance #stocks #global #equities #markets #stockmarket #stockmarkettoday #trly #cron #cannabis #marijuana
